THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON CARDIOVASCULAR PARAMETERS IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA

被引:0
|
作者
Kassianides, Xenophon
Bhandari, Sunil
机构
[1] Hull Univ, Teaching Hosp NHS Trust, Kingston Upon Hull, Yorks, England
[2] Hull York Med Sch, Kingston Upon Hull, Yorks, England
关键词
D O I
暂无
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
MO531
引用
收藏
页码:I385 / I385
页数:1
相关论文
共 50 条
  • [1] THE DIFFERENTIAL EFFECT OF THIRD GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON PATIENT RELATED OUTCOME MEASURES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANAEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I383 - I384
  • [2] THE DIFFERENTIAL EFFECT OF THIRD-GENERATION INTRAVENOUS IRON PREPARATIONS (FERRIC CARBOXYMALTOSE, FERRIC DERISOMALTOSE) ON HEMATINIC AND RENAL FUNCTION VARIABLES IN PATIENTS WITH NON-DIALYSIS DEPENDENT CKD AND IRON DEFICIENCY ANEMIA
    Kassianides, Xenophon
    Bhandari, Sunil
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2022, 37 : I379 - I380
  • [3] INTRAVENOUS FERRIC CARBOXYMALTOSE VS ORAL IRON IN ANAEMIC PATIENTS WITH NON-DIALYSIS DEPENDENT CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY: RESULTS OF THE RANDOMISED FIND-CKD STUDY
    Macdougall, I. D.
    Bock, A.
    Carrera, F.
    Eckardt, K-U
    Gaillard, C.
    Van Wyck, D.
    Roubert, B.
    Nolen, J.
    Roger, S. D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 21 - 21
  • [4] Differential Effects of Ferric Derisomaltose and Ferric Carboxymaltose on Fatigue in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease
    Mehta, Amit R.
    Wolf, Myles
    Zoller, Heinz
    [J]. BLOOD, 2022, 140 : 2471 - 2472
  • [5] A cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anaemia in Finland
    Metsarinne, K.
    Saavuori, N.
    Ahmed, W.
    Pollock-Wilkins, R.
    Salminen, K.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1885 - I1886
  • [6] ECONOMICS OF INTRAVENOUS FERRIC CARBOXYMALTOSE FOR TREATMENT OF IRON DEFICIENT ANAEMIA IN PATIENTS WITH NON-DIALYSIS CHRONIC KIDNEY DISEASE: A PILOT STUDY IN ITALY
    Minutolo, Roberto
    Liberti, Maria Elena
    Berto, Patrizia
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [7] A randomized controlled trial comparing intravenous ferric carboxymaltose with oral iron for treatment of iron deficiency anaemia of non-dialysis-dependent chronic kidney disease patients
    Qunibi, Wajeh Y.
    Martinez, Carlos
    Smith, Mark
    Benjamin, Joseph
    Mangione, Antoinette
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (05) : 1599 - 1607
  • [8] FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
    Macdougall, Iain C.
    Bock, Andreas H.
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Nolen, Jacqueline G.
    Roger, Simon D.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (11) : 2075 - 2084
  • [9] EFFECT OF IV FERRIC CARBOXYMALTOSE ON PHYSICAL PERFORMANCE AND QOL IN PATIENTS WITH CKD NOT ON DIALYSIS, MILD ANEMIA AND IRON DEFICIENCY
    Puchades Montesa, Maria Jesus
    Casas Todoli, Juan
    Cases Amenos, Aleix
    Forquet, Claudia
    Gimenez-Civera, Elena
    Perez Bernat, Elisa
    Solano Rivera, Camila
    Muijsenberg Alcala, Andrea
    Acosta Barrios, Adriana
    Gorriz Teruel, Jose Luis
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I593 - I593
  • [10] Efficacy and cost effectiveness of intravenous ferric carboxymaltose versus iron sucrose in adult patients with iron deficiency anaemia
    Basha, Ahmad
    Ibrahim, Mohamed Izham Mohamed
    Hamad, Anas
    Chandra, Prem
    Omar, Nabil E.
    Abdullah, Mohamed Abdul Jaber
    Aldapt, Mahmood B.
    Hussein, Radwa M.
    Mahfouz, Ahmed
    Adel, Ahmad A.
    Shwaylia, Hawraa M.
    Ekeibed, Yaslem
    AbuMousa, Rami
    Yassin, Mohamed A.
    [J]. PLOS ONE, 2021, 16 (08):